137 million patients
treated with Roche medicines
19 billion tests
conducted with Roche Diagnostics products
30 Roche medicines
on the WHO Model List of Essential Medicines
Our primary contribution to healthcare is to invent and develop medicines and diagnostics that significantly improve people’s lives. This entails a commitment to working with many different partners to continuously and sustainably reduce the barriers that prevent or impede access to our products.
Engaging with our stakeholders is essential to build trust and understanding of the challenges. By truly embedding our stakeholder engagement into our daily business we are able to jointly develop solutions.
Innovating for patients
We aim to provide a work environment where our employees are encouraged to build their careers and pursue their passions. By providing everyone with the opportunity for career development, we ensure the growth of our single largest investment – our employees – and, in turn, the success of our organisation.
72%
Employee engagement rate
28% of women
in key leadership positions
24% of key leaders
with diverse work experience
Providing a great workplace
Open and constructive dialogue with our stakeholders is crucial to creating sustainable value and growth. It helps us to better understand how to serve patients, their carers and physicians, and to focus our activities on creating value for both the company and society.
41 new partnerships
in Diagnostics in 2017
118 new partnerships
in Pharmaceuticals in 2017
100% of approx. 1,000
business-critical suppliers risk-assessed
Being a trustworthy partner
We have been committed to mitigating environmental impact and climate change for many years, proactively seeking new, more sustainable technologies to achieve this goal. Also, a tradition of philanthropy has existed at Roche for more than a century. The common purpose of our activities is to make a lasting impact by building stronger and healthier communities.
11% decrease
in water consumption since 2015
9% decrease
in energy consumption since 2015
20% improvement
in the eco-balance since 2014
Protecting the environment and supporting communities
We aim to continuously create value for our stakeholders and to achieve sustainable, high profitability. We do this in order to maintain our commitment to research, to ensure our growth and independence, to provide employment opportunities, to cover risks, and to pay an attractive return on invested capital.
+5%
in Group sales
+3%
in core operating profit
9 years in a row
Group leader in Dow Jones Sustainability Index